Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

Repligen (NASDAQ:RGEN) will present at the Bank of America Securities 2026 Global Healthcare Conference in Las Vegas on May 12-14, 2026.

Rhea-AI Summary

Repligen (NASDAQ:RGEN) will present at the Bank of America Securities 2026 Global Healthcare Conference in Las Vegas on May 12-14, 2026. CFO Jason Garland will take part in an analyst-led discussion on May 12 at 10:00am PT.

A live webcast will be available on Repligen's Investor Relations website with a limited-time replay following the event.

Argus May 7 session

+0.53% close to close Open Argus

Details

News Market Reaction – RGEN

On May 7, the day this news came out, RGEN closed 0.53% above the previous close.

Data tracked by StockTitan Argus for the May 7 session.

Market Context

This announcement outlines Repligen’s participation in a major healthcare investor conference, with ...

Analysis

This announcement outlines Repligen’s participation in a major healthcare investor conference, with its CFO speaking on May 12 at 10:00am PT. Similar prior conference notices had limited direct impact compared with earnings and guidance updates. Investors may focus on any commentary delivered at the event in the context of recent Q1 2026 growth, restructuring efforts disclosed in the 10-Q, and recent insider share sales when assessing future developments.

Key Figures

Conference dates: May 12–14, 2026 Presentation time: 10:00am PT

Conference dates

May 12–14, 2026

Bank of America Securities 2026 Global Healthcare Conference

Presentation time

10:00am PT

Analyst-led discussion on May 12, 2026

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Q1 2026 earnings

   24h Move

   +6.3%

   Revenue growth and raised adjusted EPS guidance with strong cash position.

2. Apr 22

   Earnings date notice

   24h Move

   -5.0%

   Scheduling announcement for Q1 2026 results and conference call details.

3. Apr 17

   Facility expansion

   24h Move

   +3.2%

   Opening European Training & Innovation Center to expand customer support.

4. Mar 05

   Conference participation

   24h Move

   -0.6%

   Planned participation in three March 2026 investor conferences.

5. Feb 24

   FY2025 earnings

   24h Move

   -0.5%

   Strong 2025 revenue growth and 2026 guidance with margin expansion targets.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

webcast

1 terms

webcast technical

"A live webcast of the conference presentation will be accessible"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global Healthcare Conference, being held May 12-14 in Las Vegas, Nevada. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on May 12 at 10:00am PT.

A live webcast of the conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, Germany, Ireland, the Netherlands and Sweden. For more information about the Company see our website at www.repligen.com, and follow us on LinkedIn.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Repligen (RGEN) present at the Bank of America Securities 2026 Global Healthcare Conference?

Repligen will participate at the conference held May 12-14, 2026. According to the company, the event takes place in Las Vegas and includes an analyst-led discussion on May 12 at 10:00am PT featuring CFO Jason Garland.

Who from Repligen (RGEN) will speak at the May 2026 Bank of America conference?

CFO Jason Garland will participate in an analyst-led discussion on May 12 at 10:00am PT. According to the company, the session is part of the Bank of America Securities 2026 Global Healthcare Conference in Las Vegas.

How can investors watch Repligen's (RGEN) presentation at the May 2026 conference?

A live webcast will be accessible via Repligen's Investor Relations website. According to the company, the webcast will also be available for replay for a limited period after the event.

Will Repligen's (RGEN) May 12, 2026 conference presentation be available after the event?

Yes. According to the company, a replay of the live webcast will be available for a limited period following the event on Repligen's Investor Relations website, allowing investors to view the discussion after May 12.

What time should investors tune in to hear Repligen (RGEN) at the Bank of America 2026 conference?

Tune in on May 12 at 10:00am PT for the analyst-led discussion featuring CFO Jason Garland. According to the company, the live webcast will stream on Repligen's Investor Relations website with limited replay availability.